Spain – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Suministro, respetuoso co
Dirección del Instituto Nacional de Gestión Sanitaria (INGESA) awarded a contract of undisclosed value to Novo Nordisk Pharma, S.A. for Construction & Public Works in April 2025 — one of 358 awards this buyer has made.
Winning supplier
Novo Nordisk Pharma, S.A.Contract description
Spain – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Suministro, respetuoso con el medio ambiente, de medicamentos de Factor VIII de coagulación recombinante, para varias comunidades autónomas y centros de Instituto Nacional de Gestión Sanitaria (INGESA) en Ceuta y Melilla
Related awards · Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)
358 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-484252-2024HORI-HORI, S.A.€5.0M12 Aug 2024 Professional Services
- ocds-ted-117395-2025GETINGE GROUP SPAIN, S.L.U.€4.5M21 Feb 2025 Construction
- ocds-ted-118779-2025GETINGE GROUP SPAIN, S.L.U.€4.5M21 Feb 2025 Construction
Other wins · Novo Nordisk Pharma, S.A.
15 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección del Instituto Nacional de Gestión Sanitaria (INGESA) and Novo Nordisk Pharma, S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back